Trial by Ordeal of Unprecedented Global Pandemic

Our CEO, Mario Papillon, was interviewed by Clinical Trials Insight on how Cerba Research helps clients receive novel treatments faster, and how our key differentiators have helped us in the fight against COVID-19.

Download the article using the button below, or read a copy on the Clinical Trials Insight website: https://secure.viewer.zmags.com/publication/955cc33c#/955cc33c/18

Covid-19 and its Ripple Effect on Clinical Trials

Our team came together to write an article on Covid-19 and its ripple effect on clinical trials for the Journal for Clinical Studies. Sofie Vandevyver, Daniel Tanner and Mario Papillon discussed the challenges Covid-19 revealed in clinical trials, the overwhelming amount of different assays for the detection of Covid-19 and which ones to use in clinical studies, and what the future of clinical trials might look like.

Download the article using the button below, or read a copy on the Journal for Clinical Studies’ website (https://issuu.com/mark123/docs/2020-jcs-3-june-web_compressed/22).

Africa: an advantageous landscape for conducting clinical trials

Strategic partnerships to provide unique solutions

Protein Biomarkers Overview

Fact Sheet – Clinical Trials at Cerba Research